Shares of Oxford BioMedica plc (LON:OXB) opened at 3.1053 on Friday. The company’s 50 day moving average is GBX 3.57 and its 200 day moving average is GBX 4.58. The firm’s market capitalization is GBX 82.75 million. Oxford BioMedica plc has a 12-month low of GBX 2.98 and a 12-month high of GBX 8.45.
In other Oxford BioMedica plc news, insider Tallarigo ,Lorenzo purchased 62,257 shares of the business’s stock in a transaction that occurred on Thursday, August 25th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £2,490.28 ($3,035.08). Also, insider Lorenzo Tallarigo purchased 79,988 shares of the business’s stock in a transaction that occurred on Monday, September 26th. The stock was acquired at an average cost of GBX 3 ($0.04) per share, with a total value of £2,399.64 ($2,924.61).
Oxford BioMedica plc Company Profile
Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company’s segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners.
Receive News & Ratings for Oxford BioMedica plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica plc and related companies with MarketBeat.com's FREE daily email newsletter.